Vanguard Group Inc. Has $2.19 Billion Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Vanguard Group Inc. cut its position in The Cooper Companies, Inc. (NASDAQ:COO) by 0.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,849,281 shares of the medical device company’s stock after selling 40,579 shares during the period. Vanguard Group Inc. owned 11.95% of Cooper Companies worth $2,192,464,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in COO. Raymond James Trust N.A. raised its stake in shares of Cooper Companies by 22.3% in the third quarter. Raymond James Trust N.A. now owns 3,140 shares of the medical device company’s stock worth $346,000 after purchasing an additional 573 shares during the last quarter. Cerity Partners LLC grew its holdings in Cooper Companies by 56.4% during the third quarter. Cerity Partners LLC now owns 19,179 shares of the medical device company’s stock worth $2,116,000 after buying an additional 6,916 shares in the last quarter. Daiwa Securities Group Inc. raised its position in Cooper Companies by 3.6% in the 3rd quarter. Daiwa Securities Group Inc. now owns 31,811 shares of the medical device company’s stock valued at $3,510,000 after buying an additional 1,102 shares during the last quarter. Brown Brothers Harriman & Co. lifted its stake in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares in the last quarter. Finally, Bank of Montreal Can boosted its holdings in Cooper Companies by 51.4% during the 3rd quarter. Bank of Montreal Can now owns 326,520 shares of the medical device company’s stock worth $35,845,000 after acquiring an additional 110,878 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Analyst Ratings Changes

COO has been the topic of a number of recent analyst reports. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus reduced their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Finally, Robert W. Baird reduced their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research note on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Stock Performance

Shares of COO opened at $83.86 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $16.77 billion, a price-to-earnings ratio of 43.01, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The stock’s 50-day simple moving average is $89.66 and its 200 day simple moving average is $97.62.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.